Research Article

Use of PEGylated Recombinant Human Growth Hormone in Chinese Children with Growth Hormone Deficiency: A 24-Month Follow-Up Study

Table 2

Treatment-related adverse events reported in each group.

PEGylated rhGH group (n = 49)Daily rhGH group (n = 49)
N (%)N (%)

Hypothyroidism2 (4.1%)3 (6.1%)
Peripheral edema00
Headache00
Injection-site lipoatrophy00
Diabetes mellitus00